gilead hiv - Search News

News

FDA Approves HIV Shot That’s 99.9% Effective

Barron's on MSN · 3d

FDA Approves Gilead’s HIV Shot. It Works 99.9% of the Time.

The Food and Drug Administration approved a twice-yearly shot that prevented HIV infections in 99.9% of the people who received it in large clinical trials. The drug, developed by Gilead Sciences and called Yeztugo,

USA TODAY on MSN · 2d

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

CNBC on MSN · 3d

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.

2d

Gilead Sciences (NasdaqGS:GILD) Gains FDA Approval For Yeztugo As PrEP HIV Option

Gilead Sciences (NasdaqGS:GILD) recently achieved FDA approval for Yeztugo, a significant step in HIV prevention as the first ...

1h

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

Fierce Pharma3d

FDA signs off on Gilead's landmark long-acting PrEP med, signaling new era in HIV prevention

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

Pharmalittle: We’re reading about FDA forcing out top gene therapy regulator, Gilead’s HIV challenges and more

And more pharma news updates from Pharmalittle.

3d

US approves twice-yearly HIV jab in ‘breakthrough moment’ for fight against Aids

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

5don MSN

Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now. Nevertheless, the company suffered a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results